Phreesia (NYSE:PHR) Hits New 1-Year Low – Time to Sell?

Shares of Phreesia, Inc. (NYSE:PHR) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $11.28 and last traded at $11.67, with a volume of 189946 shares. The stock had previously closed at $12.06.

Analyst Ratings Changes

PHR has been the subject of a number of research analyst reports. BMO Capital Markets assumed coverage on Phreesia in a report on Thursday, November 13th. They issued an “outperform” rating and a $32.00 price target for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $35.00 price objective on shares of Phreesia in a report on Monday, December 8th. Canaccord Genuity Group dropped their target price on shares of Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a report on Tuesday, December 9th. Zacks Research lowered shares of Phreesia from a “strong-buy” rating to a “hold” rating in a report on Tuesday, January 6th. Finally, Wall Street Zen downgraded shares of Phreesia from a “strong-buy” rating to a “buy” rating in a research report on Sunday, February 8th. Seventeen research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Phreesia presently has an average rating of “Moderate Buy” and a consensus price target of $29.12.

Phreesia Price Performance

The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.44 and a current ratio of 2.44. The firm has a market capitalization of $712.87 million, a P/E ratio of -118.34 and a beta of 0.67. The business has a fifty day moving average of $14.14 and a 200-day moving average of $19.61.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.11. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The company had revenue of $120.33 million during the quarter, compared to analyst estimates of $119.98 million. During the same quarter in the previous year, the firm posted ($0.25) EPS. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. On average, sell-side analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In related news, SVP Amy Beth Vanduyn sold 2,202 shares of the company’s stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $36,024.72. Following the completion of the sale, the senior vice president owned 157,349 shares of the company’s stock, valued at $2,574,229.64. This represents a 1.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Allison C. Hoffman sold 3,995 shares of the firm’s stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total transaction of $65,358.20. Following the transaction, the general counsel directly owned 169,661 shares in the company, valued at approximately $2,775,653.96. The trade was a 2.30% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 60,766 shares of company stock valued at $1,013,817. 5.50% of the stock is currently owned by insiders.

Institutional Trading of Phreesia

Hedge funds and other institutional investors have recently made changes to their positions in the business. Federated Hermes Inc. bought a new stake in shares of Phreesia during the 3rd quarter worth $32,000. Asset Management One Co. Ltd. acquired a new position in Phreesia during the third quarter valued at $45,000. Van ECK Associates Corp lifted its position in shares of Phreesia by 78.7% in the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after purchasing an additional 1,102 shares in the last quarter. KBC Group NV lifted its position in Phreesia by 83.4% in the 4th quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after buying an additional 1,568 shares in the last quarter. Finally, State of Alaska Department of Revenue purchased a new position in Phreesia in the third quarter valued at about $83,000. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.